SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

   Report of Foreign Private Issuer

 

Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of
1934


December 11th, 2008
 
Commission File Number 001-14978
 

SMITH & NEPHEW plc
 (Registrant's name)

15 Adam Street
London, England WC2N 6LA
(Address of registrant's principal executive offices)


[Indicate by check mark whether the registrant files or will file annual
reports under cover Form 20-F or Form 40-F.]
 
   Form 20-F  X                   Form 40-F
    ---                                   ---
 
[Indicate by check mark if the registrant is submitting the Form 6-K in
paper as permitted by Regulation S-T Rule 101(b)(1).]
 
Yes                            No  X
---                               ---
 
      [Indicate by check mark if the registrant is submitting the Form 6-K in
 paper as permitted by Regulation S-T Rule 101(b)(7).]
 
Yes                            No  X
---                              ---
 
     [Indicate by check mark whether by furnishing the information contained
in this Form, the registrant is also thereby furnishing information to the
 Commission pursuant to Rule 12g3-2 (b) under the Securities Exchange Act of
1934.]
 
                  Yes                            No  X
                        ---                               ---
 
     If "Yes" is marked, indicate below the file number assigned to the
registrant in connection with Rule 12g3-2 (b) : 82- n/a.
 


 

SIGNATURES

 

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 


                                                         Smith & Nephew Plc
                                                 (Registrant)


Date: December 11th, 2008
 


                                                                       By:   /s/ Paul Chambers
                                                        -----------------
                                                 Paul Chambers
                                                 Company Secretary
 

 

CEO Round table

11 December 2008

Smith & Nephew plc (LSE: SN, NYSE: SNN), the global medical technology business, 
announces that, as part of its ongoing communications programme, Dave Illingworth, Chief Executive Officer, will today be holding a routine round table meeting with analysts to discuss the 
Company's strategy and longer term views on 
its
 target markets. A copy of the presentation will be available on 
the Smith & Nephew
 website 
at 
www.smith-nephew.com
later today. No material new information will be disclosed and the 
Company will give an 
outlook for 2009 as normal at our Preliminary Results presentation in February 2009.


About Us

Smith & Nephew is a global medical technology business, specialising in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies; Endoscopy and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies. 

Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2007 were nearly $3.4 billion.


Enquiries:

Investors/Analysts

Julie Allen
Tel: +44 (0)20 7401 7646
Corporate Affairs Co-ordinator

Smith & Nephew plc



Media

Jon Coles
Brunswick
 - 
London
+44 (0) 20 7404 5959


Cindy Leggett-Flynn 
Brunswick
 - 
New York
+1 (212) 333 3810